Jean B.

p. 1 Created with Analyst Reporter Printed: 15/02/2010 2:34:00 PM Quantitative Peak Review 1^ 7 K1000911 -013 5.30 PFBA 1 213.0/169.0 Da Baseline Missed i : Wronn Peak .. ( 4.25 1i 13C-PFBA 217.0/172.0 Da Baseline Missed n Wronn Peak ,..i 6.31 ......

AfLRa.6 _ 0&3i BIODEGRADATION (BOD/COD) TEST SUBSTAN CE____________________________________________ Identity: A mixture containing perfluorooctanesulfonate, which may also be referred to as PFOS, FC-95 or as a component of FC-201AF. (1Octanesulfonic acid) (CAS # 2795-39-3).

BEST CO PY AVAILABLE "/6 # 6 From Barnard J Madly o ti 10/15/2001 12:3 PM To cc: Subject M Ann BM0ay/3TM)UPQDUP.

AR226-3371 DuPont Central Research and Development April 11, 1994 3M Center Bldg?

Disclaimer: This email and the information contained therein and within any attachments is confidential and may be privileged.

CYBER ESSENTIALS PLUS Original Appointment From: Sent: Tuesday, October 10, 2023 10:24 AM To: Subject: FW: AGC site visit When: 26 October 2023 13:00-15:00 (UTC+00:00) Dublin, Edinburgh, Lisbon, London.

Comment on Proposed Restriction of PFAS Aug 25, 2023 Japan Valve Manufactures' Association (JVMA) Japan Valve Manufacturers Association (JVMA) appreciates the opportunity to provide comments to the PFAS restriction proposal. 1.

AGC Y0111 Dreams, 0111- Ch,lHerlge SAFETY DATA SHEET 10-01-2023 FLUON SAA-1000 / SAA-1000 U6 / SAA-1000 U8 According to REACH Regulation (EC) No 1907/2006, as amended by UK REACH Regulations SI 2019/758 and SI 2020/1577 SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1 Product identifier Product Name FLUON SAA-1000 / SAA-1000 U6 / SAA-1000 U8 1.2 Relevant identified uses of the substance or mixture and uses advised against Identified Use(s) Fluoropolymer polymerisation aid.

Policy Position December 2021 Risk-based regulation for per- and poly-fluoroalkyl substances (PFAS) PFAS play an important role in some vital products that improve quality and longevity of life.

General Comments for Annex XV restriction report on Per- and polyfluoroalkyl substances (PFAS) 22 May 2023 We welcome the opportunity to contribute to the public consultation initiated by the European Chemicals Agency regarding potential restriction of Per- and polyfluoroalkyl substances (PFAS) according to Regulation (EC) No. 1907/2006 ("REACH").

3M MMDICAL DEPARTTYIENT TOXICOLOGY SERVICES cc:John Butenhoff From: Marv Case Subject: Covance Study6329-222 Date: 27 July1998 On 22 July1998 when I was atCovance Madison, I reviewedthemicroscopiclivertissue sectionsof themonkeys on the4-week oralrangefmderstudyofPFOS (Covance study 6329-222).There was no evidenceof compound-relatedeffectisntheliveerven inthe highdose animals.Our toxicologyconsultanthsad askedthequestionwhetherthehigh dose monkeys had any evidenceoflivernecrosisor any othermicroscopicevidence adverselivereffects.The answer isnegative.

Argus PK Outline 5/03/2000 One Generation -R-eproductioSntudy of PFOS in Itats Pharmacoldnetic Analy Study Outline Study Objectives:This studywillserveasa follow-upstudyto Combined Oral(gavagg) EtrlW.

BIOACCUMULATION (ANALYTICAL ONLY) TEST SUBSTANCE Identity:N-ethylperfluorooctanseulfonamidoethanol;may alsobe referredtoas N-ETFOSE Alcoholor FM-3422. (1-Octanesulfonamide,N-ethyl1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-(2-hydroxyethyl)-, CAS # 1691-99-2) Remarks: Materialisan off-whitew,axy solidofuncharactedzed purity.